That FGF23 is only activating towards UUOF, injury-primed fibroblasts, also seems broadly consistent with the epidemiological evidence, which shows that risk estimates for CKD differ depending on the stage of disease. This evidence concerns the gene FGF23 and chronic kidney disease.